Enhabit, Inc. (NYSE:EHAB) Receives $9.35 Consensus Target Price from Analysts

Enhabit, Inc. (NYSE:EHAB) has received an average rating of “Reduce” from the seven analysts that are presently covering the firm, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating and six have assigned a hold rating to the company. The average twelve-month price objective among brokerages that have updated their coverage on the stock in the last year is $9.25.

Separately, Leerink Partners reaffirmed a “market perform” rating and issued a $8.00 price objective (down previously from $8.50) on shares of Enhabit in a research report on Tuesday.

Hedge Funds Weigh In On Enhabit

Several large investors have recently made changes to their positions in the company. FMR LLC raised its position in Enhabit by 138.4% during the third quarter. FMR LLC now owns 3,388 shares of the company’s stock worth $27,000 after acquiring an additional 1,967 shares during the period. Gladius Capital Management LP purchased a new stake in shares of Enhabit during the second quarter worth $31,000. Quarry LP grew its holdings in shares of Enhabit by 242.2% during the second quarter. Quarry LP now owns 3,703 shares of the company’s stock worth $33,000 after buying an additional 2,621 shares in the last quarter. Allspring Global Investments Holdings LLC purchased a new stake in shares of Enhabit during the first quarter worth $44,000. Finally, ProShare Advisors LLC purchased a new stake in shares of Enhabit during the first quarter worth $118,000.

Enhabit Trading Down 0.6 %

Shares of EHAB opened at $7.41 on Tuesday. Enhabit has a 1-year low of $6.85 and a 1-year high of $11.74. The company has a 50-day moving average of $7.52 and a 200 day moving average of $8.42. The firm has a market capitalization of $372.69 million, a price-to-earnings ratio of -3.19 and a beta of 1.84. The company has a debt-to-equity ratio of 0.85, a current ratio of 1.46 and a quick ratio of 1.46.

Enhabit (NYSE:EHAB) last announced its quarterly earnings data on Wednesday, November 6th. The company reported $0.03 earnings per share for the quarter, missing analysts’ consensus estimates of $0.04 by ($0.01). Enhabit had a negative net margin of 11.24% and a positive return on equity of 1.67%. The company had revenue of $253.60 million for the quarter, compared to the consensus estimate of $261.69 million. During the same quarter in the previous year, the business earned $0.03 EPS. On average, research analysts expect that Enhabit will post 0.25 EPS for the current year.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.